Latest news

In the News / Mar 27, 2026

Agni Bio Selected to Present AGB101 (Vβ17 x DLL3) Poster at AACR Annual Meeting 2026 Agni Bio, Inc., a biotechnology company developing next-generation immunotherapies, today announced that it has been selected to present a poster highlighting its AGB101 (Vβ17 x DLL3) program at the AACR Annual Meeting 2026 in the Late Breaking Poster Session, taking place April 17–22, 2026 in Sa...

Read more

In the News / Mar 24, 2026

Agni Bio Selected to Present at AACR Oncology Industry Partnering Event 2026 Agni Bio, Inc., a biotechnology company advancing next-generation immunotherapies for cancer, today announced that it has been selected for an oral presentation at the AACR Oncology Industry Partnering Event: From Cancer Discoveries to Patients, taking place April 16–17, 2026 at the San Diego Con...

Read more

In the News / Feb 09, 2026

Agni Bio Presents Preclinical Data on AGB201 at AACR Immuno-Oncology Conference 2026 Agni Bio, Inc., a biotechnology company focused on developing innovative immunotherapies for cancer, today announced the presentation of new preclinical data for AGB201 at the AACR Immuno-Oncology Conference 2026, held February 18–21, 2026 in Los Angeles and organized by the American Association ...

Read more